“The effectiveness and safety of subcutaneous immunotherapy for inhalable allergens in patients with respiratory allergies after one year of treatment”, Rev Alerg Mex, vol. 67, no. 4, pp. 309–315, Feb. 2021, doi: 10.29262/ram.v67i4.758.